Evofem Biosciences, Inc. | Business Contracts

Second Amendment to Securities Purchase Agreement, dated as of September 15, 2022, by and among Evofem Biosciences, Inc., Adjuvant Global Health Technology Fund, LP, and Adjuvant... (Filed With SEC on September 16, 2022)

Form of Right (Filed With SEC on September 16, 2022)

Office Sublease, dated as of May 27, 2022, by and between Evofem Biosciences, Inc. and AMN Healthcare, Inc (Filed With SEC on August 12, 2022)

Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on March 10, 2022)

Amendment No. 1 to Amended and Restated License Agreement, by and between Rush University Medical Center and Evofem, Inc., dated September 29, 2020 (Filed With SEC on November 9, 2020)

Supply and Manufacturing Agreement, dated November 4, 2019, by and between the Registrant and DPT Laboratories, Ltd (Filed With SEC on March 12, 2020)

Third Amendment to Securities Purchase and Security Agreement, dated as of September 15, 2022, by and among Evofem Biosciences, Inc., certain institutional investor and their... (Filed With SEC on September 16, 2022)

Form of Adjuvant Exchange Agreement (Filed With SEC on September 16, 2022)

Form of Investor Exchange Agreement (Filed With SEC on September 16, 2022)

Subordination Agreement, dated as of September 15, 2022, by and among Global Health Technology Fund, LP, Adjuvant Global Health Technology Fund, DE, LP, and certain institutional... (Filed With SEC on September 16, 2022)

Forbearance Agreement, dated as of September (Filed With SEC on September 16, 2022)

Form of Common Warrant To Purchase Common Stock (Filed With SEC on May 23, 2022)

Form of Pre-Funded Warrant To Purchase Common Stock (Filed With SEC on May 23, 2022)

Underwriting Agreement, dated as of May 20, 2022, by and between Evofem Biosciences, Inc. and Piper Sandler & Co (Filed With SEC on May 23, 2022)

Form of Warrant (Filed With SEC on May 5, 2022)

Form of Senior Subordinated Note (Filed With SEC on May 5, 2022)

Form of Amendment and Exchange Agreement For Existing Notes (Filed With SEC on May 5, 2022)

Form of Amendment and Exchange Agreement For Preferred Stock (Filed With SEC on May 5, 2022)

Form of Amendment and Exchange Agreement For Equity Line Shares (Filed With SEC on May 5, 2022)

First Amendment to Securities Purchase Agreement, dated as of October 14, 2020, by and among Evofem Biosciences, Inc., Adjuvant Global Health Technology Fund, LP, and Adjuvant... (Filed With SEC on April 7, 2022)

Form of Exchange Agreement (Filed With SEC on March 24, 2022)

Second Amendment to Securities Purchase and Security Agreement, dated as of April 23, 2020, by and among Evofem Biosciences, Inc., certain affiliates of Baker Bros. Advisors LP,... (Filed With SEC on March 21, 2022)

Description of Evofems securities registered pursuant to Section 12(b) of the Securities Exchange Act of 1934 (Filed With SEC on March 10, 2022)

Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on March 10, 2022)

Form of Securities Purchase Agreement (Filed With SEC on March 1, 2022)

Form of Senior Subordinated Note (Filed With SEC on March 1, 2022)

Form of Warrant (Filed With SEC on March 1, 2022)

Purchase Agreement (Filed With SEC on February 16, 2022)

Securities Purchase Agreement (Filed With SEC on January 13, 2022)

Form of Senior Subordinated Note (Filed With SEC on January 13, 2022)

Form of Warrant (Filed With SEC on January 13, 2022)

First Amendment to Securities Purchase and Security Agreement, dated as of April 23, 2020, by and among Evofem Biosciences, Inc., certain affiliates of Baker Bros. Advisors LP, as... (Filed With SEC on November 22, 2021)

Confidential Employment Transition Plan and General Release Agreement, dated November 12, 2021 (Filed With SEC on November 15, 2021)

Securities Purchase Agreement, dated October 11, 2021 (Filed With SEC on October 12, 2021)

Form of Warrant to Purchase Common Stock (Filed With SEC on May 19, 2021)

Underwriting Agreement, dated as of May 17, 2021, between Evofem Biosciences, Inc.and H.C. Wainwright & Co., LLC (Filed With SEC on May 19, 2021)

Underwriting Agreement, dated as of March 24, 2021, among Evofem Biosciences, Inc., Morgan Stanley & Co. LLC and Stifel, Nicolaus & Company, Incorporated (Filed With SEC on March 25, 2021)

Description of Evofems securities registered pursuant to Section 12(b) of the Securities Exchange Act of 1934 (Filed With SEC on March 4, 2021)

Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on March 4, 2021)

Evofem Biosciences, Inc. Incentive Recoupment Policy (Filed With SEC on March 4, 2021)

Evofem Biosciences, Inc. Amended and Restated 2018 Inducement Equity Incentive Plan (Filed With SEC on March 4, 2021)

Evofem Biosciences, Inc (Filed With SEC on March 4, 2021)

Letter Agreement, dated as of October 14, 2020, by and between Evofem Biosciences, Inc., Adjuvant Global Health Technology Fund, L.P. and Adjuvant Global Health Technology Fund... (Filed With SEC on October 15, 2020)

Registration Rights Agreement, dated as of October 14, 2020, by and between Evofem Biosciences, Inc., Adjuvant Global Health Technology Fund, L.P. and Adjuvant Global Health... (Filed With SEC on October 15, 2020)

Form of Convertible Promissory Note (Filed With SEC on October 15, 2020)

Securities Purchase Agreement, dated as of October 14, 2020, by and between Evofem Biosciences, Inc., Adjuvant Global Health Technology Fund, L.P. and Adjuvant Global Health... (Filed With SEC on October 15, 2020)

Underwriting Agreement, dated as of June 2, 2020, among Evofem Biosciences, Inc., Morgan Stanley & Co. LLC and Piper Sandler & Co (Filed With SEC on June 3, 2020)

Evofem Biosciences, Inc. Amended and Restated 2014 Equity Incentive Plan (Filed With SEC on May 12, 2020)

First Amendment to Office Lease, dated as of April 14, 2020, by and between the Registrant and Kilroy Realty, L.P (Filed With SEC on May 6, 2020)

Securities Purchase and Security Agreement, dated as of April 23, 2020, by and between Evofem Biosciences, Inc., its wholly-owned domestic subsidiaries as guarantors, certain... (Filed With SEC on April 27, 2020)

Form of Warrant (Filed With SEC on April 27, 2020)

Form of Registration Rights Agreement (Filed With SEC on April 27, 2020)

Intellectual Property Security Agreement, dated as of April 23, 2020 by and between Evofem Biosciences, Inc., certain of its wholly-owned domestic subsidiaries and Baker Bros.... (Filed With SEC on April 27, 2020)

Form of Note (Filed With SEC on April 27, 2020)

Rights Agreement, dated as of March 24, 2020, by and between the Company and Philadelphia Stock Transfer, Inc., as rights agent (Filed With SEC on March 25, 2020)

Description of Evofems securities registered pursuant to Section 12(b) of the Securities Exchange Act of 1934 (Filed With SEC on March 12, 2020)

Evofem Biosciences, Inc. 2019 Employee Stock Purchase Plan (Filed With SEC on June 5, 2019)

Evofem Biosciences, Inc. Amended and Restated 2014 Equity Incentive Plan (Filed With SEC on June 5, 2019)

Consulting Agreement, dated as of April 1, 2019, by and between Evofem Biosciences Operations, Inc. and Thomas Lynch (Filed With SEC on May 7, 2019)

Registration Rights Agreement (Filed With SEC on April 11, 2019)

Securities Purchase Agreement (Filed With SEC on April 11, 2019)

Form of Warrant for Woodford (Filed With SEC on April 11, 2019)

Form of Warrant (Filed With SEC on April 11, 2019)

Form of Repricing Letter Agreement (Filed With SEC on February 11, 2019)

Form of Reload Warrant (Filed With SEC on February 11, 2019)

Form of Repricing Letter Agreement (Filed With SEC on February 11, 2019)

Form of Reload Warrant (Filed With SEC on February 11, 2019)

Evofem Biosciences, Inc. (70)